Ethical Implications of Editing Genetic Factors in Neurodegenerative Diseases for Future Immunologists

1. Introduction 2. Background on Neurodegenerative Diseases 2.1 Overview of Common Diseases 2.2 Genetic Factors Involved 2.3 Current Treatment Limitations 3. Genetic Editing Techniques 3.1 CRISPR-Cas9 Technology 3.2 Alternative Genetic Editing Methods 3.3 Potential for Disease Modification 4. Ethical Considerations in Genetic Editing 4.1 Consent and Patient Rights 4.2 Long-term Effects and Unknowns 4.3 Socioeconomic Disparities 5. Implications for Immunologists 5.1 Role in Treatment Development 5.2 Ethical Challenges in Practice 5.3 Collaboration with Geneticists 6. Case Studies 6.1 Successful Examples 6.2 Controversial Cases 6.3 Lessons Learned 7. Future Research Directions 7.1 Advancements in Technology 7.2 Addressing Ethical Challenges 7.3 Interdisciplinary Approaches 8. Conclusion